NCT05304585 2026-02-24Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaChildren's Oncology GroupPhase 3 Recruiting205 enrolled